Amid the ongoing probe into the Red Fort bomb blast, a fresh scrutiny of foreign-trained doctors brings long-standing ...

Bengaluru: Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, ...

Bengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced ...

For people younger than 55 years, frailty’s consequences appear to be more severe and its drivers more apt to be ...

The World Endoscopy Organization consensus statement offers guidance to support the safe and responsible integration of AI endoscopy tools into clinical practice.

New trials highlight Pathlight’s performance in the neoadjuvant triple-negative breast cancer (TNBC) settingMORRISVILLE, N.C.--(BUSINESS WIRE)--#BreastCancer--SAGA Diagnostics®, a pioneer in ...

Data demonstrates neflamapimod treatment led to significant reductions in plasma glial fibrillary acidic protein ( GFAP), a key marker of neuroinflammation-associated neurodegeneration, and increased ...

Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including hemogl ...

Significant reduction in key neurodegeneration biomarker correlated with treatment response, suggesting neflamapimod may act on underlying disease CervoMed preparing to initiate Phase 3 registrational ...

India and Russia have been strategic partners for more than 70 years. But what’s the reason behind this years-long friendship ...

Rashid Khalani is the Chief Executive Officer of the Aga Khan University Hospital, a world-class medical centre and teaching institution in Nairobi, Kenya. During a recent guided media tour of the ...

First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability ...